GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 325 filers reported holding GUARDANT HEALTH INC in Q2 2020. The put-call ratio across all filers is 2.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $12,995 | -96.9% | 363 | -91.3% | 0.00% | -100.0% |
| Q4 2021 | $417,000 | -44.4% | 4,167 | -30.6% | 0.00% | -50.0% |
| Q3 2021 | $750,000 | -1.8% | 6,002 | -2.4% | 0.00% | 0.0% |
| Q2 2021 | $764,000 | -76.3% | 6,149 | -70.9% | 0.00% | -76.5% |
| Q1 2021 | $3,224,000 | +203.6% | 21,117 | +156.1% | 0.02% | +240.0% |
| Q4 2020 | $1,062,000 | +8.8% | 8,244 | -5.5% | 0.01% | -16.7% |
| Q3 2020 | $976,000 | +33.9% | 8,727 | -2.9% | 0.01% | 0.0% |
| Q2 2020 | $729,000 | +2.1% | 8,988 | -12.3% | 0.01% | -33.3% |
| Q1 2020 | $714,000 | +1247.2% | 10,253 | +1416.7% | 0.01% | +800.0% |
| Q4 2019 | $53,000 | +23.3% | 676 | 0.0% | 0.00% | – |
| Q3 2019 | $43,000 | -27.1% | 676 | -1.3% | 0.00% | -100.0% |
| Q2 2019 | $59,000 | +11.3% | 685 | -0.1% | 0.00% | 0.0% |
| Q1 2019 | $53,000 | +96.3% | 686 | -5.5% | 0.00% | – |
| Q4 2018 | $27,000 | – | 726 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |